CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to create a novel vaccine platform using chimeric influenza virus-like particles to enhance the immune response against malaria. By modifying the hemagglutinin protein, the platform can incorporate various antigens, allowing for efficient vaccination strategies against malaria infections.
The goal of this project is to provide a new antigen delivery system for vaccination purpose.
We want to develop a vaccine platform based on pseudo-viral particles (VLP), able to enhance antigen immunogenicity and allow for screening multiple antigens independently or simultaneously. A chimeric influenza-VLP platform will be construct, where hemagglutinin (HA) protein will be modified to accommodate exogenous peptides containing B- and/or T- cell epitopes, thus allowing foreign antigen incorpora…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
